Developmental Changes in Modulation of Calcium Currents of Rabbit Ventricular Cells by Phosphodiesterase Inhibitors
Toshiaki Akita, MD; Ronald W. Joyner, MD, PhD; Chengbiao Lu, MD; Rajiv Kumar, PhD; H. Criss Hartzell, PhD Background We have previously shown major differences in 1-adrenergic and muscarinic modulation of L-type calcium currents (Ia) in newborn and adult rabbit heart. However, little is known about developmental changes in modulation of I, by phosphodiesterases (PDEs), which also regulate intracellular cAMP concentration by its hydrolysis.
Methods and Resuls Enzymatically isolated adult and new-
born (1to 3-day-old) rabbit ventricular myocytes were used to study the effects of PDE inhibitors on Ic, measured by the whole-ell patch-clamp method. 3-Isobutyl-1-methyl-xanthine (IBMX), a nonselective PDE inhibitor, increased Ic. in a dose-dependent manner for both groups. The maximal effect of IBMX, expressed as percentage increase in I% over control levels, was greater for newborn myocytes than for adult myocytes, but the effects of IBMX applied alone were observed only at concentrations >10 umol/L. The concomitant use of 0.1 jmol/L isoproterenol produced a significant potentiation of the IBMX effect on Ic,, with a significant additive effect of IBMX in newborn myocytes even at 0.05 .mol/L IBMX. The concomitant use of a subthreshold concentration of IBMX (0.1 ,umol/L) did not potentiate the dose dependence of adult Ic on isoproterenol but did markedly potentiate the dose dependence of newborn I% on isoproterenol. The E. and EC50 of isoproterenol in the presence of 0.1 ,umol/L IBMX C alcium current (Ica) through high-threshold (Ltype) Ca2' channels plays an important role of regulating action potential duration as well as excitation-contraction coupling in cardiac myocytes. The modulation of this channel by p-adrenergic agonists and muscarinic acetylcholine agonists from sympathetic and parasympathetic nerve stimulation is a major mechanism for the regulation of heart rate and contractility.
f-Adrenergic agonists enhance Ica in cardiac myocytes by binding of an agonist to a f-adrenergic receptor, which then activates a guanine nucleotidebinding protein, G,. This protein then stimulates the activity of adenylyl cyclase and produces an increase in the level of intracellular cAMP.1 This process is followed by the phosphorylation of the Ca'+ channel or its subunits through a cAMP-dependent protein ki-© 1994 American Heart Association, Inc. on newborn Ica were 235% and 8 nmol/L, respectively, whereas the Em. and EC50 of isoproterenol in the absence of IBMX on newborn Ica were 111% and 81 nmol/L, respec- tively. The addition of 50 ,umol/L IBMX to 10 ,umol/L isoproterenol markedly increased the newborn Ic, density up to a level equivalent to that reached with 200 gmol/L cAMP in the pipette (14.9±1.2 versus 13.4±0.7 pA/pF). Our data suggest that the inhibition constant (Kj) of IBMX for inhibiting PDEs that participate in the regulation of ICa is much lower in newborn than in adult myocytes. Milrinone 1 ,umol/L, a selective PDE III inhibitor, increased the 0.1 gmol/L isoproterenol-stimulated Ica of adult myocytes but had no significant additive effect for the 0.1 1tmol/L isoproterenol-stimulated Ica of newborn myocytes. Rolipram 1 ,mol/L, a selective PDE IV inhibitor, increased the 0.1 gmol/L isoproterenol-stimulated I% for newborn myocytes but had no significant additive effect for the 0.1 1A/L isoproterenol-stimulated Ica for adult myocytes. stimulation antagonizes the 3-adrenergic stimulation of Ic, through an indirect and/or direct inhibition of adenylyl cyclase, with this inhibitory response mediated by another G protein, Gi.4
We recently described postnatal developmental changes of 3-adrenergic and muscarinic modulation of ICiS6 in rabbit ventricular myocytes. In summary, the efficacy of isoproterenol to stimulate Ica is lower in newborn (1to 3-day-old) than in adult rabbit ventricular myocytes, and the efficacy of carbachol to inhibit isoproterenol-stimulated or forskolin-stimulated lc,a is much greater in newborn than in adult myocytes. Pertussis toxin treatment of newborn myocytes increased the levels of basal Ica, produced a much stronger response to isoproterenol, and completely blocked the actions of carbachol. These data and previous biochemical studies7-9 suggest that a tonic Gi inhibition of adenylyl cyclase is present in newborn myocytes and that the overall balance between influences of Gi and Gs on the activity of adenylyl cyclase seems to favor Gi effects in newborn myocytes and Gs effects in adult myocytes.
The intracellular cAMP concentration is determined not only by the rate of cAMP production by adenylyl cyclase but also by the rate of hydrolysis by phosphodiesterases (PDEs). Age-related differences of inotropic effects of PDE inhibitors have been reported,10'11 with amrinone or milrinone, inhibitors of cGMP-inhibited PDE, having a much weaker inotropic effect on newborn papillary muscle than on adult papillary muscles. Kithas et al12 reported postnatal developmental changes in the activity of PDE isozymes in both the soluble and the particulate fractions of rabbit heart muscle.
According to the current guidelines for PDE nomenclature,13 cAMP is hydrolyzed to 5'-AMP by at least four classes of PDE isozymes: (1) a Ca calmodulin-dependent PDE (PDE I), which hydrolyzes both cAMP and cGMP and whose cAMP hydrolytic activity is dependent on Ca2' and calmodulin; (2) a cGMP-stimulated PDE (PDE II), which hydrolyzes both cAMP and cGMP with low affinity (high Ki) and whose cAMP hydrolytic activity is stimulated by cGMP; (3) a cGMP-inhibited PDE (PDE III), which hydrolyzes cAMP with high affinity (low K.) and whose cAMP hydrolytic activity is inhibited by cGMP; and (4) a cAMP-specific PDE (PDE IV), which hydrolyzes only cAMP with high affinity (Ki) and is also referred to as a cGMP-insensitive or rolipramsensitive PDE.
The regulation of cAMP hydrolysis is less well documented, and it remains unclear whether and how these different types of PDE contribute to the regulation of ICa.14-18 In addition, not all of these PDE types may be functional in cardiac myocytes. Bode et al19 were able to separate four PDE types from homogenates of whole rat ventricle, but homogenates produced from isolated ventricular myocytes lacked activity of the calmodulindependent PDE I. Furthermore, there are no reports about developmental changes in the role of PDEs in the regulation of Ica. This study was designed to examine postnatal changes in the modulation of L-type 'Ca in mammalian hearts by inhibitors of PDE enzymes. We compared the effects of 3-isobutyl-1-methyl-xanthine (IBMX, a nonselective PDE inhibitor), milrinone (a selective PDE III inhibitor), and rolipram (a selective PDE IV inhibitor) on L-type Ica in freshly dissociated adult and newborn rabbit ventricular myocytes under nearly identical experimental conditions using the whole-cell voltage clamp technique.
Methods

Cell Preparation
New Zealand White adult (1.5 to 2.5 kg) and newborn (1to 3-day-old) rabbits of either sex were used in the experiments. Adult rabbits were first heparinized (1000 U IV) and anesthetized with sodium pentobarbital (50 mg/kg IV). For newborn rabbits, the same drugs were given intraperitoneally. Hearts were rapidly removed via thoracotomy with artificial ventilation, and the aorta was cannulated. Single ventricular myocytes were obtained from adult and newborn hearts by enzymatic dissociation as we previously described. 20 In brief, hearts were mounted on a Langendorif apparatus and perfused sequentially with normal Tyrode's solution for 5 to 6 minutes, nominally Ca2-free Tyrode's solution for S to 8 minutes, the same solution containing 0.05 to 0.12 mg/mL collagenase (Yakult Co) and 0.01 mg/mL protease (type XIV, Sigma Chemical Co) for 5 to 9 minutes, and a storage solution for 5 minutes at a rate of 3 to 4 mL g-1 . min-1 at 33°C to 34°C. The ventricle was cut into small pieces, pipetted, and filtered by a mesh. The isolated myocytes were kept in the storage solution at 4°C.
Solutions
The compositions of solutions used were as follows (in mmolIL): normal Tyrode's solution, NaCl 148.8, KCl 4.0, CaCl2 1.8, MgCl2 0.53, NaHPO4 0.33, HEPES 5, glucose 5, pH 7.4 with NaOH; Ca2-free Tyrode's solution, NaCl 100, KCl 10, KH2P04 1.2, MgSO4 5, taurine 50, glucose 20, HEPES 10, pH 7.1 with NaOH; storage solution, potassium glutamate 120, MgCl2 5, taurine 20, EGTA 1, glucose 10, HEPES 10, pH 7.4 with KOH; test solution, NaCl 130, CaCl2 1.8, CsCI 20, MgCl2 0.53, HEPES 5, glucose 5, pH 7.4 with NaOH; and pipette solution, CsOH 110, aspartic acid 90, CsCI 20, HEPES 5, EGTA 10, tetraethylammonium chloride 10, MgATP 5, Na2 creatine phosphate 5, GTP (Tris) 0.4, leupeptin (Sigma Chemical Co) 0.1, pH 7.2 with CsOH. Pipettes had resistances of 1.5 to 3 MQi for adult ventricular myocytes and 2.5 to 6 MQl for newborn ventricular myocytes before seal formation and access resistances of 2.5 to 10 MQl during the data recordings.
The drugs used in the experiments were isoproterenol [(-)-isoproterenol HCl], IBMX, and milrinone from Sigma. Rolipram was a gift from Berlex Chemical Co. Solutions for isoproterenol were freshly prepared from stock solution as described previously.5 IBMX, milrinone, and rolipram were dissolved in DMSO at a concentration at least 1000 times the test solution.
Data Acquisition
Electrophysiological recordings were conducted using the whole-cell configuration of the patch-clamp technique with an Axopatch-1B patch amplifier (Axon Instruments) as we previously described20 with compensation for series resistance.
For routine monitoring of Ic, the ventricular myocyte was depolarized every 10 seconds from a holding potential of -40 mV to a test potential of +15 mV for 180 milliseconds. No leakage correction was required. This test voltage is based on the peak current of the I-V relations for both control and isoproterenol-stimulated Ica as previously published.5'20 We showed previously that currents elicited with this protocol are stable over long periods of time and are completely blocked by nitrendipine.20 The elicited Ica was filtered at a corner frequency of 2 kHz, digitized at 200-microsecond intervals, and stored and analyzed on an IBM-compatible computer with pCLAMP software (Axon Instruments). I%, was measured as the peak inward current. All experiments were performed at room temperature (21°C to 23°C). Ventricular myocytes with a membrane capacitance <100 pF were used for the experiments. Cells that had "rundown" of I%, were excluded from the analysis by accepting data only from myocytes in which %, was stable in the control condition and reached a stable effect with the drugs tested.
Statistical analysis was performed with SYSTAT for Windows (SYSTAT). Statistical significance between two groups was determined by Student's t test for paired or unpaired data, as appropriate. When more than two groups were compared, statistical significance was determined by one-way ANOVA.
When a significant F value was detected, then Tukey's twotailed test was performed to determine a significant difference between each group. Values of P<.05 were regarded as significant. Data are presented as mean+SEM. in adult (left) and newborn (right) ventricular myocytes. In both adult and newborn myocytes, 10 ,umol/L IBMX was the apparent threshold concentration to increase Ic.a In the adult cell, after application of 100 ,umol/L IBMX, 'Ca reached a steady state (122% over the control level) within 10 minutes (inset in lower left of Fig 1) , and the Ica density returned to control levels by subsequently washing out IBMX (data not shown). The stimulatory effect of 100 ,umol/L IBMX on newborn Ilc (212% over the control level) was larger than on the adult Ic., with a similar time course.
Results
Dose-Dependent Effects of IBMX on
The dose-dependent effect of IBMX on basal Ica is summarized in Fig 2. Dose-response relations are presented here and in subsequent figures as percent increase in lc,a because the basal current densities in the present experiments were about twice as great for the adult myocytes (4.21+0.21, n=27) as for the newborn myocytes (2.10±0.11, n=36), similar to values we have presented previously.20 IBMX caused a dose-dependent increase in Ica density with a threshold concentration of about 10 ,umol/L for both adult and newborn myocytes (P<.05 from basal Ica). The effect of IBMX to stimulate basal Ica at concentrations above 30 umol/L was significantly greater in newborn than in adult myocytes (P<.05). The stimulatory effect of IBMX on ICa reached maximum at the concentration of about 100 gmol/L for adult myocytes and 300 ,Lmol/L for newborn myocytes, respectively. The continuous curves were derived from nonlinear least-mean-squares regression of the means to the Michaelis equation. The maximal effect (Ema,) of IBMX to stimulate Ic,a (expressed as percent increase in Ica over control levels) and the concentration for one half of the maximal effect (EC50) obtained by this analysis were 159±29% and 71±33 ,mol/L, respectively, for adult and 317+31% and 64±20 gmol/L, respectively, for newborn myocytes. Unlike the maximal effect of isoproterenol, which increases Ica by 203% for adult and 111% for newborn,5 respectively, the maximal effect of IBMX to stimulate basal Ic, was greater in newborn than in adult.
Dose-Dependent Effects of IBMX on Isoproterenol-Stimulated lCa Current
Ventricular myocytes in situ receive f3-adrenergic stimulation through circulating catecholamines in the blood and through sympathetic innervation, which stimulates cAMP production by activating adenylyl cyclase. We investigated the effects of IBMX with concomitant application of isoproterenol, since the potency and efficacy of IBMX to stimulate Ilc might be different under conditions of higher cAMP production because the four types of PDE isozymes have different Km and 
,umol/L IBMX on lCa
We examined whether a subthreshold concentration of IBMX had an effect on the isoproterenol doseresponse curve on 'Ca in adult and newborn myocytes. In adult myocytes, the percent increase in Ic, stimulated by low concentrations of isoproterenol (0.01 and 0.1 ,umol/L) with 0.1 ,mol/L IBMX seemed slightly higher than that by isoproterenol alone; however, it did not reach statistical significance. Emax and EC50 of isoproterenol with 0.1 ,umol/L IBMX to stimulate Ica for adult myocytes were 187±15% and 31±15 nmol/L, respectively. Those of isoproterenol alone to stimulate 'Ca for adult myocytes were 203±5% and 51±8 nmol/L, respectively. In contrast to adult myocytes, the stimulatory effect of isoproterenol at all concentrations tested on newborn Ilc was markedly potentiated by 0.1 ,umol/L IBMX (P<.01). Emax and EC50 of isoproterenol with 0.1 ,umol/L IBMX to stimulate Ica for newborn myocytes were 235±6% and 8±1 nmol/L, respectively. Those of isoproterenol alone to stimulate Ica for newborn myocytes were 111±2% and 81±5 nmol/L. The addition of 0.1 ,mol/L IBMX not only potentiated the efficacy two times but also increased the potency of isoproterenol to stimulate newborn ICa by one log unit.
Effects of IBMX on 'Ca Increased by a Supramaximal Dose of Isoproterenol
We previously reported that in newborn myocytes the maximum isoproterenol-stimulated Ica density was significantly lower than either the maximum forskolinstimulated or 200 ,umol/L cAMP (in the pipette)stimulated 'Ca for newborn myocytes. The lower stimulatory effect of isoproterenol in newborn myocytes may be partly explained by the tonic inhibition by Gi protein of adenylyl cyclase, and subsequent smaller production of cAMP by adenylyl cyclase after pretreatment by pertussis toxin of newborn myocytes markedly enhanced the isoproterenol effect on ICs5,6 However, the intracellular cAMP concentration is determined by the balance of cAMP production by adenylyl cyclase and its hydrolysis by PDE. To evaluate the relation between cAMP production by maximum ,B-adrenergic stimulation and cAMP hydrolysis by PDE, we studied adult and newborn myocytes in which we first exposed each cell to 10 ,umol/L isoproterenol and then added 50 ,umol/L IBMX. The present study was focused on postnatal changes in PDE modulation of L-type Ilc of rabbit ventricular myocytes. Our results obtained in this study using IBMX, a nonselective PDE inhibitor, are summarized as follows:
1. The efficacy of IBMX to stimulate basal Ic, (expressed as percent increase over control current level) was significantly greater for newborn myocytes than for adult myocytes, whereas the potency of IBMX for newborn was almost the same as that for adult. 2. The efficacy and potency of the additional effect of IBMX when applied concomitantly with 0.1 ,umol/L isoproterenol to stimulate Ica were significantly greater for newborn myocytes than for adult myocytes. The potency of IBMX to stimulate Ica was increased by concomitant use of 0.1 ,umol/L isoproterenol with much greater potentiation in newborn than in adult. 3. The efficacy and potency of isoproterenol to stimulate Ica were markedly potentiated by concomitant use of 0.1 ,umol/L IBMX in newborn myocytes, whereas in adult myocytes there was no significant potentiation by 0.1 ,mol/L IBMX of the response to isoproterenol.
4. The addition of 50 gmol/L IBMX markedly enhanced newborn Ilc after application of a supramaximal concentration of isoproterenol (10 ,umol/L) up to a level equivalent to that reached with 200 umol/L cAMP in the pipette. There was no significant additive effect of 50 ,umol/L IBMX on 10 ,umol/L isoproterenol-stimulated adult 1Ca. It is well established that 'Ca as well as contractility of cardiac muscles is modulated by cAMP-dependent phosphorylation.1,3,24"27-30 Increase in cAMP concentration activates cAMP-dependent protein kinase (PK-A) by binding its regulatory subunits. Activated PK-A phosphorylates various intracellular proteins, including L-type calcium channel, phospholamban, and troponin I. 30 Phosphorylation of L-type Ca21 channels by PK-A leads to an increase in the mean probability of channel opening and channel availability.2,3 Some of the PDE inhibitors are reported to increase Ic, by elevating the intracellular cAMP concentration through inhibiting hydrolysis of cAMP by PDE. 14, 16, 24 Therefore, the effect of PDE inhibitors to stimulate Ic. depends on the increase in cAMP concentration achieved by inhibition of cAMP breakdown and does not directly depend on the extent of inhibition of PDE activity. The potency of IBMX to increase intracellular cAMP concentration would be greater when the concentration or the production rate of cAMP is higher, which would thus affect the potency of this drug to stimulate Ic, and contractility of cardiac muscles. Actually, without the application of isoproterenol, IBMX had a very low potency to stimulate Ica in both newborn and adult myocytes in our experiments, whereas, with the concomitant application of 0.1 ,umol/L isoproterenol, a marked potentiation of the IBMX effect was demonstrated both in newborn and adult, with much greater potentiation in newborn than in adult. The application of 0.1 pimol/L IBMX did not significantly potentiate the isoproterenol-stimulated current at any concentration we tested in adult myocytes, whereas 0.1 ,umol/L IBMX significantly potentiated the isoproterenol-stimulated current at all concentrations we tested in newborn myocytes (Fig 4) . These results clearly show that 0.1 gmol/L IBMX is below the threshold concentration to inhibit PDE of adult myocytes and above the threshold concentration to inhibit PDE of newborn myocytes. IBMX potentiated the 0.1 ,mol/L isoproterenol-stimulated Ic, from 1 ,mol/L in adult and from 0.05 ,mol/L in newborn (Fig 3, bottom) . Therefore, PDEs of newborn myocytes, which modulate Ica, seem at least 10 times more sensitive to IBMX than those of adult. In other words, the effective Ki value of IBMX for PDEs that regulate Ica seems to be much lower in newborn myocytes than in adult myocytes.
The similar low potency of IBMX to stimulate Ica in both newborn and adult myocytes compared with the higher potency (newborn>adult) for increasing the isoproterenol-stimulated I% and the distinctly lower estimated Ki value of IBMX in newborn than in adult myocytes suggest that the basal level of cAMP concentration for newborn myocytes is much lower than for adult myocytes. This does not necessarily mean that the actual concentrations of cAMP are lower in newborn than in adult myocytes, because the cAMP dose-response relation for Ica may not be the same in newborn as in adult. Ica or single Ca2' channel activity is regulated by interaction of phosphorylation by protein kinase and dephosphorylation by phosphatase of subunits of its channel.Y"31 Therefore, a difference in the activity of protein kinases as well as that of phosphatases between newborn and adult cardiac myocytes could influence the dose-response of cAMP for Ica and change the potency of cAMP between newborn and adult. We have recently shown that microcystin, a potent phosphatase 1 and 2A inhibitor, has much greater stimulatory effect on newborn Ic, than adult ones, which suggests that phosphatase activity to regulate Ica may be much higher in newborn myocytes than in adult myocytes.32
There are several possibilities to explain this distinctly different Ki value of IBMX between the PDE for adult versus newborn myocytes. One is that there may be a developmental change in the characteristics of PDEs concerning sensitivity to IBMX. Artman et a133 reported that the Ki value of piroximone to cytosolic low-Km cGMP-inhibitable PDE differs significantly between adult and immature rabbit heart, although the Ki of piroximone for adult was found to be 30 times lower than that for newborn. The second possibility is that the 
distribution of types of PDE isozymes in newborn rabbit heart might be quite different from that in adult. 12 Although IBMX is reported to be a nonselective PDE inhibitor with similar IC50 or Ki values to each PDE isozyme,2634 the overall Ki value to IBMX might be different between newborn and adult if there were a large difference of PDE isozymes between adult and newborn heart (discussed below). Another possibility is that IBMX may be acting other than as a PDE inhibitor, which could influence the sensitivity or estimated Ki value of IBMX by increasing the Ica. IBMX has a strong antagonistic effect on A1-adenosine receptors, resulting from a structural homology between adenosine and IBMX, which have a common ring structure. Adenosine has been reported to antagonize the stimulatory effect of isoproterenol on ICa. 35 However, this side action of IBMX is unlikely to explain the stimulatory effect on Ic in our results. The amount of adenosine a single cell produces is unlikely to be sufficiently high to activate adenosine receptors, especially because the myocytes are constantly superfused at a relatively high rate of 2.5 mL/min through 0.3 mL tissue bath.'5 Furthermore, we have shown that 8-cyclopentyl-1,3-dipropyl-xanthine (DPCPX), a strong A1-adenosine receptor antagonist that does not inhibit PDE, was ineffective in potentiating the isoproterenol effect on I% (unpublished data).
These results indicate that the effects of IBMX were not due to the action of adenosine receptor antagonism. Kithas.12 They analyzed the postnatal change in cytosolic PDE isozyme activity as well as the subcellular distribution of high-affinity cAMP PDEs in rabbit ventricular myocardium and demonstrated that, in the soluble fraction of rabbit ventricular muscle, cGMPinhibitable, milrinone-sensitive PDE activity is much higher in adult than in newborn, whereas cGMP-insensitive, rolipram-sensitive PDE is the dominant type in the soluble fraction of newborn rabbit ventricular muscle. It is interesting that PDE IV is the dominant isozyme in frog heart,34 which is evolutionarily primitive, and in newborn heart, which is developmentally immature.12
Effects of Milrinone and
The ineffectiveness of milrinone for stimulating newborn Ic may explain, at least in part, the reported10'11 weaker inotropic effect of this cardiotonic PDE III inhibitor in newborn heart than in adult heart. Since Ilc is the major source of Ca21 influx into ventricular myocytes and influxed Ca21 is taken up and released by sarcoplasmic reticulum, a weaker ability of a PDE III inhibitor to increase Ica may result in a weaker inotropic response to milrinone for newborn myocytes. The weaker inotropic response by PDE III inhibitors for newborn hearts might also be explained by the immaturity of sarcoplasmic reticulum in newborn heart.36 '37 In rabbit or canine hearts, the PDE from the membrane-bound fraction, which represents basically the sarcoplasmic reticulum fraction, consists largely of PDE III,12,38,39 which is the target of cardiotonic PDE III inhibitors. According to Kithas,12 this membrane-bound PDE III activity increases fivefold during maturation.
Clinical Relevance
Our results have several important points of clinical relevance in treating heart failure during the neonatal period, especially during the postoperative low cardiac output state of congenital heart disease. The decreased 3-adrenergic stimulation of Ica that we have reported,5 as well as the decreased modulation of contractility for newborn rabbit heart reported by others,40 has demonstrated that, in newborn hearts, the isoproterenol responses were much less effective than direct adenylyl cyclase stimulation with forskolin. However, we have now shown that the addition of 50 ,mol/L IBMX to isoproterenol increased the Ica density up to the equivalent level obtained with forskolin or intracellular application of 200 ,umol/L cAMP. Also, additions of low concentrations of either IBMX or rolipram significantly potentiated the effect of isoproterenol for newborn IC.
We have also done experiments with measurements of developed isovolumic pressure in Langendorff-perfused adult and newborn rabbit hearts and have shown that 0.1 ,umol/L IBMX strongly potentiates the inotropic effect of isoproterenol in newborn but not in adult rabbit hearts (unpublished data). Therefore, the concomitant use of /-adrenergic stimulation and PDE inhibitors has a potential to overcome the weaker response of p-adrenergic stimulation on I"c as well as on contractility for newborn hearts. Our data predict that PDE IV inhibitors, not PDE III inhibitors, which are used as cardiotonic drugs for adult hearts, may be the most effective in achieving an additive effect on newborn contractility.
